Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Haisco Pharmaceutical Group Registers Delaware Subsidiary to Expand Global Operations
Company

Haisco Pharmaceutical Group Registers Delaware Subsidiary to Expand Global Operations

February 10, 2025
Beijing Luzhu Submits BLA for LZ901 Herpes Zoster Vaccine to NMPA
CompanyDrug

Beijing Luzhu Submits BLA for LZ901 Herpes Zoster Vaccine to NMPA

February 10, 2025
Hainan Boao Lecheng Pilot Zone Implements Baclofen Intrathecal Therapy
CompanyDrug

Hainan Boao Lecheng Pilot Zone Implements Baclofen Intrathecal Therapy

February 10, 2025
Xtalpi Invests in Alternative Bio for Cancer and Inflammation Drugs
CompanyDeals

Xtalpi Invests in Alternative Bio for Cancer and Inflammation Drugs

February 10, 2025
NMPA's New Guidelines for Drug Registration Review
Policy / Regulatory

NMPA’s New Guidelines for Drug Registration Review

February 10, 2025
Shanghai's Three-Year Plan to Boost Elderly Care Quality
Policy / Regulatory

Shanghai’s Three-Year Plan to Boost Elderly Care Quality

February 10, 2025
NMPA Approves Sinocelltech's Finotonlimab for Head and Neck Cancer
CompanyDrug

NMPA Approves Sinocelltech’s Finotonlimab for Head and Neck Cancer

February 10, 2025
Tianjin Municipality Boosts Biopharmaceutical Industry with New Measures
Policy / Regulatory

Tianjin Municipality Boosts Biopharmaceutical Industry with New Measures

February 10, 2025
Hansoh Pharma's Uplizna Receives Priority Review for IgG4-RD Treatment
CompanyDrug

Hansoh Pharma’s Uplizna Receives Priority Review for IgG4-RD Treatment

February 10, 2025
NMPA Seeks Public Feedback on Export Drug Manufacturing Rules
Policy / Regulatory

NMPA Seeks Public Feedback on Export Drug Manufacturing Rules

February 10, 2025
VectorBuilder and Eureka Bio Form Alliance to Advance CGT Solutions Globally
CompanyDeals

VectorBuilder and Eureka Bio Form Alliance to Advance CGT Solutions Globally

February 10, 2025
China's Drug Procurement Under Scrutiny: Addressing Quality Concerns and Policy Reforms
Policy / Regulatory

China’s Drug Procurement Under Scrutiny: Addressing Quality Concerns and Policy Reforms

February 10, 2025
1 2 … 254 255 256 257 258 … 289 290
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up